News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tupper Colleen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 31,640 shares
@ $23.7726, valued at
$752.2k
|
|
| 03/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/14/2023 |
4
| Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 45,045 shares
@ $0
Granted 12,565 shares
@ $0
Paid exercise price by delivering 6,967 shares
@ $26.75, valued at
$186.4k
Paid exercise price by delivering 3,887 shares
@ $26.75, valued at
$104k
|
|
| 10/06/2022 |
4
| Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 4,350 shares
@ $17.35, valued at
$75.5k
|
|
| 03/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/14/2022 |
4
| Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 45,500 shares
@ $0
Granted 4,212 shares
@ $0
Paid exercise price by delivering 2,821 shares
@ $17.63, valued at
$49.7k
Paid exercise price by delivering 1,237 shares
@ $17.63, valued at
$21.8k
|
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|